Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
DGX
DGX
NYSE
Health Services
Services to the Health Industry
227.86
USD
-0.04
-0.02%
Fermé: 07-24 20:00 (UTC+0)
227.86
USD
+0
+0.00%
Après-clôture: 07-25 00:00 (UTC+0)

DGX Statistiques clés

Haut
233.21
Ouverture
228.00
Volume
1.54M
Bas
223.42
Clôture précédente
227.90
Valeur négociée
353.86M
Plus haut 52 sem.
237.78
Vol. relatif
1.414
Amplitude (%)
4.30%
Plus bas 52 sem.
165.78
Taux de rotation
1.39%
Cap. Marché
25.14B
PER (TTM)
24.17
PER (Annuel)
25.689
P/B
3.35
P/S
2.18
Bénéfice par action (BPA)
9.427
Dividende (TTM)
3.737
Rendement du dividende
1.44%
Actions en circulation
110.69M
Devise
USD

DGX Performance du Prix

7 jour
30 jour
90 jour
180 jour
Depuis le début de l’année
1 An
DGX Répartition des flux monétaires
DGX Volume quotidien des ventes à découvert
DGX Historique du short interest
As of 2026-07-26, the Quest Diagnostics Incorporated (DGX) stock price today is 227.86. Based on this price, the company has a market capitalization of $25.14B, with a P/E ratio of 24.17. On 2026-07-26, DGX traded between 223.42 and 233.21. Today’s stock price is 1.99% above the daily low and 2.29% below the daily high, placing DGX près du milieu de its most recent trading range. Trading volume currently stands at 1.54M, compared with an average daily volume of 1.09M. This suggests that trading activity is supérieur à son niveau habituel than usual. Over the past year, Quest Diagnostics Incorporated shares have traded between 165.78 and 237.78. At today’s price, DGX is 37.45% above its 52-week low and 4.17% below its 52-week high.
Nom l'entreprise
Quest Diagnostics Incorporated
Secteur
Health Services
Industrie
Services to the Health Industry
Exchanges
NYSE
Nombre d’employés
57,000
Taille du lot
100
Devise
USD
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

DGX FAQ

Recherche
Plus